Differential expression of genes associated with cell proliferation and apoptosis induced by okadaic acid during the transformation process of BALB/c 3T3 cells

Toxicology in Vitro

Volumn 22, Issue 1, 2008, Pages 116-127

  Ao, Lin ^a   Liu, Jin yi ^a   Gao, Li hong ^a   Liu, Sheng xue ^a   Yang, Meng su ^b   Huang, Ming hui ^b   Cao, Jia ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

BALB c 3T3 cells; cDNA microarray; Cell transformation; Okadaic acid

Indexed keywords

FLUORESCENT DYE; HOE 33342; LIPOCORTIN 5; METHYLNITRONITROSOGUANIDINE; OKADAIC ACID; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; BAG1 GENE; BNIP3 GENE; CARCINOGENESIS; CASP3 GENE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN 3T3; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; CYCS GENE; DOWN REGULATION; FLOW CYTOMETRY; GENE; GENE EXPRESSION PROFILING; GENE TARGETING; GENETIC TRANSCRIPTION; IER3 GENE; MDM2 GENE; MICROARRAY ANALYSIS; MITOCHONDRION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION;

EID: 37349085827     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2007.08.013     Document Type: Article

References (70)

1. Andersen M.E., Mills J.J., Jirtle R.L., and Greenlee W.F. Negative selection in hepatic tumor promotion in relation to cancer risk assessment. Toxicology 102 (1995) 223-237
2. Asada S., Sasaki K., Tanaka N., Takeda K., Hayashi M., and Umeda M. Detection of initiating as well as promoting activity of chemicals by a novel cell transformation assay using v-Ha-ras-transfected BALB/c 3T3 cells (Bhas 42 cells). Mutat. Res. 588 (2005) 7-21
3. Boudreau R.T., and Hoskin D.W. The use of okadaic acid to elucidate the intracellular role(s) of protein phosphatase 2A: lessons from the mast cell model system. Int. Immunopharmacol. 5 (2005) 1507-1518
4. Burns D.J., and Bell R.M. Protein kinase C contains two phorbol ester binding domains. J. Biol. Chem. 266 (1991) 18330-18338
5. Bursch W., Chabicovsky M., Wastl U., Grasl-Kraupp B., Bukowska K., Taper H., and Schulte-Hermann R. Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility. Toxicol. Sci. 85 (2005) 515-529
6. Cavalieri E.L., and Rogan E.G. A unifying mechanism in the initiation of cancer and other diseases by catechol quinones. Ann. NY Acad. Sci. 1028 (2004) 247-257
7. Chen G., Ray R., Dubik D., Shi L., Cizeau J., Bleackley R.C., Saxena S., Gietz R.D., and Greenberg A.H. The E1B 19K/Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis. J. Exp. Med. 186 (1997) 1975-1983
8. Choi C., and Benveniste E.N. Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses. Brain Res. Rev. 44 (2004) 65-81
9. Clarke P.A., te Poele R., Wooster R., and Workman P. Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential. Biochem. Pharmacol. 62 (2001) 1311-1336
10. Davis M.A., Chang S.H., and Trump B.F. Differential sensitivity of normal and H-ras oncogene-transformed rat kidney epithelial cells to okadaic acid-induced apoptosis. Toxicol. Appl. Pharmacol. 141 (1996) 93-101
11. Dhar A., Hu J., Reeves R., Resar L.M., and Colburn N.H. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation. Oncogene 23 (2004) 4466-4476
12. Dounay A.B., and Forsyth C.J. Okadaic acid: the archetypal serine/threonine protein phosphatase inhibitor. Curr. Med. Chem. 9 (2002) 1939-1980
13. Dunkel V.C., Rogers C., Swierenga S.H., Brillinger R.L., Gilman J.P., and Nestmann E.R. Recommended protocols based on a survey of current practice in genotoxicity testing laboratories: III. Cell transformation in C3H/10T1/2 mouse embryo cell, BALB/c 3T3 mouse fibroblast and Syrian hamster embryo cell cultures. Mutat. Res. 246 (1991) 285-300
14. Erkan M., Kleeff J., Esposito I., Giese T., Ketterer K., Buchler M.W., Giese N.A., and Friess H. Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis. Oncogene 24 (2005) 4421-4432
15. Fujiki H., and Suganuma M. Unique features of the okadaic acid activity class of tumor promoters. J. Cancer Res. Clin. Oncol. 125 (1999) 150-155
16. Fujiki H., Suganuma M., Okabe S., Sueoka E., Suga K., Imai K., and Nakachi K. A new concept of tumor promotion by tumor necrosis factor-alpha, and cancer preventive agents (-)-epigallocatechin gallate and green tea-a review. Cancer Detect. Prev. 24 (2000) 91-99
17. Gehringer M.M. Microcystin-LR and okadaic acid-induced cellular effects: a dualistic response. FEBS Lett. 557 (2004) 1-8
18. Graham R.M., Frazier D.P., Thompson J.W., Haliko S., Li H., Wasserlauf B.J., Spiga M.G., Bishopric N.H., and Webster K.A. A unique pathway of cardiac myocyte death caused by hypoxia-acidosis. J. Exp. Biol. 207 (2004) 3189-3200
19. Gupta R.W., Joseph C.K., and Foster D.A. v-Src-induced transformation is inhibited by okadaic acid. Biochem. Biophys. Res. Commun. 196 (1993) 320-327
20. Hansson A., Marin Y.E., Suh J., Rabson A.B., Chen S., Huberman E., Chang R.L., Conney A.H., and Zheng X. Enhancement of TPA-induced growth inhibition and apoptosis in myeloid leukemia cells by BAY 11-7082, an NF-kappaB inhibitor. Int. J. Oncol. 27 (2005) 941-948
21. Hegde P., Qi R., Abernathy K., Gay C., Dharap S., Gaspard R., Hughes J.E., Snesrud E., Lee N., and Quackenbush J. A concise guide to cDNA microarray analysis. Biotechniques 29 (2000) 548-550 552-554, 556 passim
22. Hikita H., Vaughan J., Babcock K., and Pitot H.C. Short-term fasting and the reversal of the stage of promotion in rat hepatocarcinogenesis: role of cell replication, apoptosis, and gene expression. Toxicol. Sci. 52 (1999) 17-23
23. IARC/NCI/EPA Working Group. Cellular and molecular mechanisms of cell transformation and standardization of transforming assays of established cell lines for the prediction of carcinogenic chemicals: overview and recommended protocols. Cancer Res. 45 (1985) 2395-2399
24. Jana N.R., and Nukina N. BAG-1 associates with the polyglutamine-expanded huntingtin aggregates. Neurosci. Lett. 378 (2005) 171-175
25. Jirtle R.L., Meyer S.A., and Brockenbrough J.S. Liver tumor promoter phenobarbital: a biphasic modulator of hepatocyte proliferation. Prog. Clin. Biol. Res. 369 (1991) 209-216
26. Katoh F., Fitzgerald D.J., Giroldi L., Fujiki H., Sugimura T., and Yamasaki H. Okadaic acid and phorbol esters: comparative effects of these tumor promoters on cell transformation, intercellular communication and differentiation in vitro. Jpn. J. Cancer Res. 81 (1990) 590-597
27. Kho P.S., Wang Z., Zhuang L., Li Y., Chew J.L., Ng H.H., Liu E.T., and Yu Q. p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis. J. Biol. Chem. 279 (2004) 21183-21192
28. Lee R.G., and Rosson D. 12-O-tetradecanoylphorbol-13-acetate induces apoptosis in renal epithelial cells through a growth signal conflict which is prevented by activated ras. Arch. Biochem. Biophys. 385 (2001) 378-386
29. Li Z., Tu X., and Wang C.C. Okadaic acid overcomes the blocked cell cycle caused by depleting Cdc2-related kinases in Trypanosoma brucei. Exp. Cell Res. 312 (2006) 3504-3516
30. Lin A., Zhi-xiong Z., Zhi-jun F., Ran H., Li-hong G., Meng-su Y., and Jia C. The design and fabrication of mouse toxicology gene chip. Carcinogenesis, Teratogenesis, Mutagenesis 18 (2006) 135-138 (in Chinese)
31. Lin C.T., Lin W.H., Lee K.D., and Tzeng P.Y. DNA mismatch repair as an effector for promoting phorbol ester-induced apoptotic DNA damage and cell killing: implications in tumor promotion. Int. J. Cancer 119 (2006) 1776-1784
32. Mansbach J.M., Mills J.J., Boyer I.J., De Souza A.T., Hankins G.R., and Jirtle R.L. Phenobarbital selectively promotes initiated cells with reduced TGF beta receptor levels. Carcinogenesis 17 (1996) 171-174
33. Messner D.J., Ao P., Jagdale A.B., and Boynton A.L. Abbreviated cell cycle progression induced by the serine/threonine protein phosphatase inhibitor okadaic acid at concentrations that promote neoplastic transformation. Carcinogenesis 22 (2001) 1163-1172
34. Miglietta A., Bozzo F., Gabriel L., Bocca C., and Canuto R.A. Extracellular signal-regulated kinase 1/2 and protein phosphatase 2A are involved in the antiproliferative activity of conjugated linoleic acid in MCF-7 cells. Brit. J. Nutr. 96 (2006) 22-27
35. Milczarek G.J., Chen W., Gupta A., Martinez J.D., and Bowden G.T. Okadaic acid mediates p53 hyperphosphorylation and growth arrest in cells with wild-type p53 but increases aberrant mitoses in cells with non-functional p53. Carcinogenesis 20 (1999) 1043-1048
36. Mohamad N., Gutierrez A., Nunez M., Cocca C., Martin G., Cricco G., Medina V., Rivera E., and Bergoc R. Mitochondrial apoptotic pathways. Biocell 29 (2005) 149-161
37. Mordan L.J., Dean N.M., Honkanen R.E., and Boynton A.L. Okadaic acid: a reversible inhibitor of neoplastic transformation of mouse fibroblasts. Cancer Commun. 2 (1990) 237-241
38. Mouratidou T., Kaniou-Grigoriadou I., Samara C., and Kouimtzis T. Detection of the marine toxin okadaic acid in mussels during a diarrhetic shellfish poisoning (DSP) episode in Thermaikos Gulf, Greece, using biological, chemical and immunological methods. Sci. Total Environ. 366 (2006) 894-904
39. Murphy E., Imahashi K., and Steenbergen C. Bcl-2 regulation of mitochondrial energetics. Trends Cardiovasc. Med. 15 (2005) 283-290
40. Nakadate T. The mechanism of skin tumor promotion caused by phorbol esters: possible involvement of arachidonic acid cascade/lipoxygenase, protein kinase C and calcium/calmodulin systems. Jpn. J. Pharmacol. 49 (1989) 1-9
41. Nguyen-Ba G., and Vasseur P. Epigenetic events during the process of cell transformation induced by carcinogens (review). Oncol. Rep. 6 (1999) 925-932
42. Parfett C.L., Marquardt T., and Pilon R. Promotion of morphological transformation by Di-n-butyltin dichloride in C3H/10T1/2 cells: prediction by prior expression of tumour promoter-responsive genes. Food Chem. Toxicol. 38 (2000) 339-349
43. Rajesh D., Schell K., and Verma A.K. Ras mutation, irrespective of cell type and p53 status, determines a cell's destiny to undergo apoptosis by okadaic acid, an inhibitor of protein phosphatase 1 and 2A. Mol. Pharmacol. 56 (1999) 515-525
44. Rami B.G., Chin L.S., Lazio B.E., and Singh S.K. Okadaic-acid-induced apoptosis in malignant glioma cells. Neurosurg. Focus 14 (2003) e4
45. Ray R., Chen G., Vande Velde C., Cizeau J., Park J.H., Reed J.C., Gietz R.D., and Greenberg A.H. BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. J. Biol. Chem. 275 (2000) 1439-1448
46. Ray R.M., Bhattacharya S., and Johnson L.R. Protein phosphatase 2A regulates apoptosis in intestinal epithelial cells. J. Biol. Chem. 280 (2005) 31091-31100
47. Ridd K., Zhang S.D., Edwards R.E., Davies R., Greaves P., Wolfreys A., Smith A.G., and Gant T.W. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin. Carcinogenesis 27 (2006) 1556-1566
48. Rivedal E., Mikalsen S.O., and Sanner T. The non-phorbol ester tumor promoter okadaic acid does not promote morphological transformation or inhibit junctional communication in hamster embryo cells. Biochem. Biophys. Res. Commun. 167 (1990) 1302-1308
49. Sakai A., and Fujiki H. Promotion of BALB/3T3 cell transformation by the okadaic acid class of tumor promoters, okadaic acid and dinophysistoxin-1. Jpn. J. Cancer. Res. 82 (1991) 518-523
50. Sakai A., Kikuchi Y., Muroi M., Masui T., Furihata C., Uchida E., Takatori K., and Tanamoto K. Overexpression of NP95 mRNA by tumor promoters in the promotion phase of a two-stage BALB/3T3 cell transformation assay. Biol. Pharm. Bull. 26 (2003) 347-351
51. Samuel S., and Bernstein L.R. Adhesion, migration, transcriptional, interferon-inducible, and other signaling molecules newly implicated in cancer susceptibility and resistance of JB6 cells by cDNA microarray analyses. Mol. Carcinog. 39 (2004) 34-60
52. Shakibaei M., Schulze-Tanzil G., Takada Y., and Aggarwal B.B. Redox regulation of apoptosis by members of the TNF superfamily. Antioxid. Redox. Signal. 7 (2005) 482-496
53. Sheu C.W., Rodriguez I., Dobras S.N., and Lee J.K. Induction of morphological transformation in BALB/3T3 mouse embryo cells by okadaic acid. Food Chem. Toxicol. 33 (1995) 883-885
54. Stahl S., Ittrich C., Marx-Stoelting P., Kohle C., Ott T., Buchmann A., and Schwarz M. Effect of the tumor promoter phenobarbital on the pattern of global gene expression in liver of connexin32-wild-type and connexin32-deficient mice. Int. J. Cancer. 115 (2005) 861-869
55. Suganuma M., Fujiki H., Suguri H., Yoshizawa S., Hirota M., Nakayasu M., Ojika M., Wakamatsu K., Yamada K., and Sugimura T. Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter. Proc. Natl. Acad. Sci. USA 85 (1988) 1768-1771
56. Suganuma M., Tatematsu M., Yatsunami J., Yoshizawa S., Okabe S., Uemura D., and Fujiki H. An alternative theory of tissue specificity by tumor promotion of okadaic acid in glandular stomach of SD rats. Carcinogenesis 13 (1992) 1841-1845
57. Suganuma M., Okabe S., Kurusu M., Iida N., Ohshima S., Saeki Y., Kishimoto T., and Fujiki H. Discrete roles of cytokines, TNF-alpha, IL-1, IL-6 in tumor promotion and cell transformation. Int. J. Oncol. 20 (2002) 131-136
58. Sun Y. p53 and its downstream proteins as molecular targets of cancer. Mol. Carcinogen 45 (2006) 409-415
59. Townsend P.A., Cutress R.I., Sharp A., Brimmell M., and Packham G. BAG-1: a multifunctional regulator of cell growth and survival. Biochim. Biophys. Acta 1603 (2003) 83-98
60. Tsuchiya T., and Umeda M. Improvement in the efficiency of the in vitro transformation assay method using BALB/3T3 A31-1-1 cells. Carcinogenesis 16 (1995) 1887-1894
61. Webster K.A., Graham R.M., and Bishopric N.H. BNip3 and signal-specific programmed death in the heart. J. Mol. Cell Cardiol. 38 (2005) 35-45
62. Weeraratna A.T. Discovering causes and cures for cancer from gene expression analysis. Ageing Res. Rev. 4 (2005) 548-563
63. Wei S., Kito K., Miyoshi A., Matsumoto S., Kauzi A., Aramoto T., Abe Y., and Ueda N. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias. J. Exp. Clin. Cancer Res. 21 (2002) 389-396
64. Wen-Sheng W. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2. Cancer Lett. 239 (2006) 27-35
65. Wu M.X. Roles of the stress-induced gene IEX-1 in regulation of cell death and oncogenesis. Apoptosis 8 (2003) 11-18
66. Yan Y., Shay J.W., Wright W.E., and Mumby M.C. Inhibition of protein phosphatase activity induces p53-dependent apoptosis in the absence of p53 transactivation. J. Biol. Chem. 272 (1997) 15220-15226
67. Yan J., Yun H., Yang Y., Jing B., Feng C., and Song-bin F. Upregulation of BNIP3 promotes apoptosis of lung cancer cells that were induced by p53. Biochem. Biophys. Res. Commun. 346 (2006) 501-507
68. Yook Y.H., Kang K.H., Maeng O., Kim T.R., Lee J.O., Kang K.I., Kim Y.S., Paik S.G., and Lee H. Nitric oxide induces BNIP3 expression that causes cell death in macrophages. Biochem. Biophys. Res. Commun. 321 (2004) 298-305
69. Yuspa S.H., Dlugosz A.A., Cheng C.K., Denning M.F., Tennenbaum T., Glick A.B., and Weinberg W.C. Role of oncogenes and tumor suppressor genes in multistage carcinogenesis. J. Invest. Dermatol. 103 (1994) 90S-95S
70. Zhang H.M., Cheung P., Yanagawa B., McManus B.M., and Yang D.C. BNips: a group of pro-apoptotic proteins in the Bcl-2 family. Apoptosis 8 (2003) 229-236